Abstract
The paradoxical growth effect (PGE; also known as Eagle effect) is an in vitro phenomenon observed during antifungal susceptibility testing (AFST). In PGE, some fungal isolates grow in medium containing high concentrations of an echinocandin, above the minimal inhibitory concentration (MIC), despite being fully susceptible at lower concentrations. The presence of PGE complicates the assignment of isolates to susceptible or resistant category, especially in the case of newly emerged pathogens like Candida auris, for which susceptibility breakpoints are not established.
Here we describe a protocol aiding in the determination of whether a given C. auris isolate is echinocandin-resistant or echinocandin-susceptible but exhibiting paradoxical growth.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Perlin DS (2015) Mechanisms of echinocandin antifungal drug resistance. Ann N Y Acad Sci 1354:1–11. https://doi.org/10.1111/nyas.12831
Barchiesi F, Spreghini E, Tomassetti S, Arzeni D, Giannini D, Scalise G (2005) Comparison of the fungicidal activities of caspofungin and amphotericin B against Candida glabrata. Antimicrob Agents Chemother 49(12):4989–4992. https://doi.org/10.1128/AAC.49.12.4989-4992.2005
Ernst EJ, Klepser ME, Ernst ME, Messer SA, Pfaller MA (1999) In vitro pharmacodynamic properties of MK-0991 determined by time-kill methods. Diagn Microbiol Infect Dis 33(2):75–80. https://doi.org/10.1016/s0732-8893(98)00130-8
Pappas PG, Kauffman CA, Andes DR, Clancy CJ, Marr KA, Ostrosky-Zeichner L, Reboli AC, Schuster MG, Vazquez JA, Walsh TJ, Zaoutis TE, Sobel JD (2016) Clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America. Clin Infect Dis 62(4):e1–e50. https://doi.org/10.1093/cid/civ933
Chowdhary A, Prakash A, Sharma C, Kordalewska M, Kumar A, Sarma S, Tarai B, Singh A, Upadhyaya G, Upadhyay S, Yadav P, Singh PK, Khillan V, Sachdeva N, Perlin DS, Meis JF (2018) A multicentre study of antifungal susceptibility patterns among 350 Candida auris isolates (2009-17) in India: role of the ERG11 and FKS1 genes in azole and echinocandin resistance. J Antimicrob Chemother 73(4):891–899. https://doi.org/10.1093/jac/dkx480
Kordalewska M, Lee A, Park S, Berrio I, Chowdhary A, Zhao Y, Perlin DS (2018) Understanding echinocandin resistance in the emerging pathogen Candida auris. Antimicrob Agents Chemother 62(6):e00238-00218. https://doi.org/10.1128/AAC.00238-18
Berkow EL, Lockhart SR (2018) Activity of CD101, a long-acting echinocandin, against clinical isolates of Candida auris. Diagn Microbiol Infect Dis 90(3):196–197. https://doi.org/10.1016/j.diagmicrobio.2017.10.021
Woodworth MH, Dynerman D, Crawford ED, Doernberg SB, Ramirez-Avila L, Serpa PH, Nichols A, Li LM, Lyden A, Tato CM, Miller S, Derisi JL, Langelier C (2019) Sentinel case of Candida auris in the Western United States following prolonged occult colonization in a returned traveler from India. Microb Drug Resist 25(5):677–680. https://doi.org/10.1089/mdr.2018.0408
CLSI (ed) (2017) Reference method for broth dilution antifungal susceptibility testing of yeast, CLSI Standard M27, 4th edn. Clinical and Laboratory Standards Institute, Wayne
Arendrup MC, Meletiadis J, Mouton JW, Lagrou K, Hamal P, Guinea J, the Subcommittee on Antifungal Susceptibility Testing (AFST) of the ESCMID European Committee for Antimicrobial Susceptibility Testing (EUCAST) (2020) EUCAST definitive document E.DEF 7.3.2 Method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for yeasts
Vanstraelen K, Lagrou K, Maertens J, Wauters J, Willems L, Spriet I (2013) The Eagle-like effect of echinocandins: what’s in a name? Expert Rev Anti-Infect Ther 11(11):1179–1191. https://doi.org/10.1586/14787210.2013.841543
Stevens DA, Espiritu M, Parmar R (2004) Paradoxical effect of caspofungin: reduced activity against Candida albicans at high drug concentrations. Antimicrob Agents Chemother 48(9):3407–3411. https://doi.org/10.1128/AAC.48.9.3407-3411.2004
Marine M, Pastor FJ, Sahand IH, Ponton J, Quindos G, Guarro J (2009) Paradoxical growth of Candida dubliniensis does not preclude in vivo response to echinocandin therapy. Antimicrob Agents Chemother 53(12):5297–5299. https://doi.org/10.1128/AAC.00980-09
Kathuria S, Singh PK, Sharma C, Prakash A, Masih A, Kumar A, Meis JF, Chowdhary A (2015) Multidrug-resistant Candida auris misidentified as Candida haemulonii: characterization by matrix-assisted laser desorption ionization-time of flight mass spectrometry and DNA sequencing and its antifungal susceptibility profile variability by Vitek 2, CLSI broth microdilution, and Etest method. J Clin Microbiol 53(6):1823–1830. https://doi.org/10.1128/JCM.00367-15
Espinel-Ingroff A, Arendrup MC, Pfaller MA, Bonfietti LX, Bustamante B, Canton E, Chryssanthou E, Cuenca-Estrella M, Dannaoui E, Fothergill A, Fuller J, Gaustad P, Gonzalez GM, Guarro J, Lass-Florl C, Lockhart SR, Meis JF, Moore CB, Ostrosky-Zeichner L, Pelaez T, Pukinskas SR, St-Germain G, Szeszs MW, Turnidge J (2013) Interlaboratory variability of caspofungin MICs for Candida spp. using CLSI and EUCAST methods: should the clinical laboratory be testing this agent? Antimicrob Agents Chemother 57(12):5836–5842. https://doi.org/10.1128/AAC.01519-13
CLSI (ed) (2020) Performance standards for antifungal susceptibility testing of yeasts, CLSI Supplement M60, 2nd edn. Clinical and Laboratory Standards Institute, Wayne
Brillowska-Dabrowska A, Nielsen SS, Nielsen HV, Arendrup MC (2010) Optimized 5-hour multiplex PCR test for the detection of tinea unguium: performance in a routine PCR laboratory. Med Mycol 48(6):828–831. https://doi.org/10.3109/13693780903531579
Centers for Disease Control and Prevention (2020) Candida auris. Information for laboratorians and health professionals. Antifungal susceptibility testing and interpretation. https://www.cdc.gov/fungal/candida-auris/c-auris-antifungal.html. Accessed 23 Apr 2021
Author information
Authors and Affiliations
Corresponding authors
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Kordalewska, M., Perlin, D.S. (2022). Deciphering Candida auris Paradoxical Growth Effect (Eagle Effect) in Response to Echinocandins. In: Lorenz, A. (eds) Candida auris. Methods in Molecular Biology, vol 2517. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-2417-3_6
Download citation
DOI: https://doi.org/10.1007/978-1-0716-2417-3_6
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-0716-2416-6
Online ISBN: 978-1-0716-2417-3
eBook Packages: Springer Protocols